Latest filing published 01 Sept 2026 for SANOFI, €117k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by olivier Charmeil span 2 companies, the busiest being Sanofi and Genoway. In total, 6 filings cover trades dated from 4 May 2023 to 20 August 2026.
Purchases make up the whole of the open-market record (2 purchases, €413k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant and 1 option exercise. So far in 2026, the count stands at 1 purchase and no sales.
The latest filing, published on 1 September 2026, reports an open-market purchase of €117k in Sanofi. Filings reach the AMF feed a median of 3 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations